| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | RGEN Repligen Corp | Hunt Anthony75 | Director | Sell | 26,756 | $152.51 | $4,080,663.26 | -2.8% | -17.5% | -21.9% | |
| Mar 17, 2025 | RGEN Repligen Corp | Pax Margaret | Director | Buy | 250 | $150.69 | $37,672.50 | +31.5% | -17.5% | -21.9% | |
| Mar 17, 2025 | DXCM Dexcom Inc | Heller Bridgette P62 | Director | Sell | 352 | $70.33 | $24,756.16 | -1.5% | +16.3% | -5.6% | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Blair Anthony K | COO | Buy | 500,000 | $0.06 | $30,000.00 | +125.0% | - | - | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Williams Rodney James | Director | Buy | 100,000 | $0.07 | $6,900.00 | +61.8% | - | - | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Jordan Scott | Chief Financial Officer | Buy | 300,000 | $0.06 | $18,600.00 | New | - | - | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | MacLeod Christopher Ross | Director | Buy | 143,000 | $0.06 | $8,437.00 | New | - | - | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Heaton Larry C II | CEO | Buy | 500,000 | $0.06 | $29,702.29 | +20.3% | - | - | |
| Mar 17, 2025 | TMCI Treace Medical Concepts, Inc. | Scanlan Sean F.65 | Chief Innovation Officer | Sell | 50,000 | $7.97 | $398,460.00 | -12.1% | -27.7% | -81.7% | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Klass Russell Kevin | Sr Vice President Of Sales | Buy | 699,980 | $0.07 | $48,998.60 | +28.0% | - | - | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Williams Rodney James | Director | Buy | 100,000 | $0.07 | $6,900.00 | New | - | - | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Rowe Jeffrey M | Director | Buy | 1,439,005 | $0.07 | $96,098.34 | +23.1% | - | - | |
| Mar 17, 2025 | BVS Bioventus Inc. | D'adamio Anthony61 | SVP &General Counsel | Sell | 2,615 | $9.75 | $25,496.25 | -2.1% | -32.7% | -8.3% | |
| Mar 17, 2025 | BVS Bioventus Inc. | Church Katrina J52 | SVP &Chief Compliance Officer | Sell | 1,018 | $9.75 | $9,925.50 | -1.9% | -32.7% | -8.3% | |
| Mar 17, 2025 | ECOR Electrocore, Inc. | Goldberger Daniel S69 | Chief Executive Officer | Buy | 1,000 | $8.59 | $8,590.00 | +0.3% | -36.8% | -17.6% | |
| Mar 17, 2025 | ZOMDF Zomedica Corp. | Powers Johnny D | Director | Buy | 500,000 | $0.07 | $33,650.00 | +3.2% | - | - | |
| Mar 17, 2025 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 8,327 | $25.12 | $209,135.52 | -8.6% | -14.0% | -25.2% | |
| Mar 14, 2025 | INCY Incyte Corp | Flannelly Barry P50 | EVP &General Manager Us | Sell | 19,807 | $67.69 | $1,340,655.93 | -12.5% | +2.0% | +36.4% | |
| Mar 14, 2025 | BLFS Biolife Solutions Inc | Duross Amy63 | Director | Sell | 5,632 | $24.96 | $140,574.72 | -19.1% | -6.8% | -26.6% | |
| Mar 14, 2025 | PDEX Pro Dex Inc | Cabillot Raymond E66 | Director, 10% Owner | Sell | 5,151 | $50.00 | $257,550.00 | -1.7% | -17.6% | -2.4% | |
| Mar 14, 2025 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 1,000,000 | $0.25 | $250,050.00 | +14.0% | -31.8% | -84.7% | |
| Mar 14, 2025 | MASI Masimo Corp | Reynolds Craig B | Director | Sell | 2,053 | $166.13 | $341,067.97 | -11.0% | -1.7% | +4.3% | |
| Mar 14, 2025 | VMD Viemed Healthcare, Inc. | Smokoff Timothy45 | Director | Sell | 11,865 | $7.70 | $91,363.75 | -2.8% | -10.4% | +21.5% | |
| Mar 14, 2025 | CERS Cerus Corp | Jensen Chrystal71 | Chief Legal Officer | Sell | 49,024 | $1.45 | $71,084.80 | -3.0% | -5.5% | +16.6% | |
| Mar 14, 2025 | CERS Cerus Corp | Benjamin Richard J71 | Chief Medical Officer | Sell | 49,024 | $1.45 | $71,084.80 | -3.4% | -5.5% | +16.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.